Trials / Completed
CompletedNCT00005881
Quality of Life in Children Treated for Cancer
Assessment of Health/Quality of Life in Survivors of Childhood Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 538 (actual)
- Sponsor
- Children's Oncology Group · Network
- Sex
- All
- Age
- 8 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Questionnaires that measure quality of life may improve the ability to plan treatment for children with cancer. PURPOSE: This randomized clinical trial is studying the quality of life in children treated for cancer.
Detailed description
OBJECTIVES: I. Assess the validity and reliability of a quality of life questionnaire (MM-QOL) that is being developed for patients with previously or currently treated childhood cancers. OUTLINE: This is a randomized, multicenter study. Patients are stratified according to age (8-12 vs 13-20) and treatment (current vs previous). Patients are randomized to one of two arms of the study. Arm I (Reliability): Patients will complete the same questionnaire two weeks apart. (age 13-20 stratum closed as of 7/14/00) Arm II (Validity): Patients will complete a study questionnaire plus a Child Health Questionnaire. Patients between ages 8-12 are interviewed and patients between ages 13-20 complete a written questionnaire. PROJECTED ACCRUAL: A total of 716 patients (416 for arm I (208 for 8-12 age group and 208 for 13-20 age group) and 300 for arm II (150 for 8-12 age group and 150 for 13-20 age group)) will be accrued for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Quality of Life Forms | Completion of the instrument \[Minneapolis-Manchester Quality of Life (MM-QOL)\] that measures HRQOL in the survivors of childhood cancer in a standardized, valid way and to assess the feasibility of incorporating this endpoint in a variety of clinical trials. |
Timeline
- Start date
- 2000-04-01
- Primary completion
- 2003-03-01
- Completion
- 2006-09-01
- First posted
- 2004-02-02
- Last updated
- 2013-08-23
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00005881. Inclusion in this directory is not an endorsement.